Bisphosphonates associated osteonecrosis of the jaw: A long‐term follow‐up of a series of 35 cases observed by GISL and evaluation of its frequency over time
Samantha Pozzi(University of Modena and Reggio Emilia), Luca Baldini(University of Milan), Simona Falorio(Azienda USL di Pescara), Vincenzo Pitini(University of Messina), Stefano Luminari(University of Modena and Reggio Emilia), Luisa Ponchio, Antonietta Falcone(Casa Sollievo della Sofferenza), Caterina Stelitano(University of Reggio Calabria), Luciano Masini(Casa di Cura Villa Garda), Giovanni Quarta(Ospedale Papa Giovanni XXIII), Raffaella Marcheselli
Cited by 12
Related Papers
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
|The Lancet|2018|733
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical Study
|Journal of Clinical Oncology|2007|374